Sara Bongiovanni
About
In The Last Decade
Sara Bongiovanni
21 papers receiving 318 citations
Peers
Comparison fields: 5 of 69
- Rheumatology 109
- Psychiatry and Mental health 81
- Pharmacology 64
- Immunology 60
- Molecular Biology 51
Countries citing papers authored by Sara Bongiovanni
This map shows the geographic impact of Sara Bongiovanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Bongiovanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Bongiovanni more than expected).
Fields of papers citing papers by Sara Bongiovanni
This network shows the impact of papers produced by Sara Bongiovanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Bongiovanni. The network helps show where Sara Bongiovanni may publish in the future.
Co-authorship network of co-authors of Sara Bongiovanni
This figure shows the co-authorship network connecting the top 25 collaborators of Sara Bongiovanni. A scholar is included among the top collaborators of Sara Bongiovanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Bongiovanni. Sara Bongiovanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 8 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 5 | |
| 6 | 13 | |
| 7 | Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data. | 5 |
| 8 | 31 | |
| 9 | 15 | |
| 10 | 1 | |
| 11 | Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study. | 36 |
| 12 | Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomes. | 10 |
| 13 | 2 | |
| 14 | 7 | |
| 15 | 3 | |
| 16 | Biomarkers in Rheumatoid Arthritis. | 46 |
| 17 | 9 | |
| 18 | 9 | |
| 19 | 23 | |
| 20 | 75 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.